Tags: Clinical Trials

blog

ADDF Grantees Headline NIH Alzheimer's Summit

ADDF-supported research was at the forefront of the Summit and the National Plan to Address Alzheimer's.

blog

Meeting the Challenge of CTE

For CTE Awareness Day, we highlight our support of diagnostic tools and treatments for this disease. 

announcements

$1.8 Million in New Funding Supports Clinical Stage Treatments

The ADDF announces nearly $1.8 million in new funding, which reflects our commitment to advancing drugs in or near human clinical trials.

blog

Top Five Alzheimer’s Advances in 2017

Our top five advances in 2017 spotlight the substantial progress we have made toward conquering Alzheimer’s and other neurodegenerative diseases.

blog

Closing in on a Cure: Dr. Roberta Diaz Brinton and Allopregnanolone

With funding from the ADDF since 2004, Dr. Roberta Diaz Brinton has developed what may become the first ever regenerative treatment for Alzheimer's disease.

announcements

Three New Grants Keep Promising Programs Forging Ahead

The Alzheimer’s Drug Discovery Foundation (ADDF) announces three new investments, all of which are for programs that the ADDF previously funded.

announcements

New Report Highlights Innovation in Alzheimer’s Clinical Trials

Closing in on a Cure: 2017 Alzheimer’s Clinical Trials Report surveys the 126 drugs in clinical development for Alzheimer’s disease—20% of which received support from the Alzheimer’s Drug Discovery Foundation. 

blog

CTAD Conference Highlights Our Funded Research

This Wednesday marks the beginning of National Alzheimer's Disease Awareness Month and the 10th Clinical Trials on Alzheimer's Disease conference, which features a record amount of research we have supported.

announcements

Dr. Roberta Diaz Brinton Wins Alzheimer's Drug Discovery Foundation's Melvin R. Goodes Prize

Dr. Brinton has pioneered a promising neurogenesis therapy for Alzheimer’s disease.

announcements

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

Nearly 200 academic and industry researchers came together to share updates on innovative preclinical and clinical-stage Alzheimer’s disease research at the 18th Annual Conference on Alzheimer's Drug Discovery.